Patents Assigned to Intercytex Limited
-
Patent number: 9271923Abstract: The present invention provides a method for the repair of subcutaneous or dermal tissue in a subject, comprising in one aspect the injection of a suspension of allogeneic dermal fibroblasts into the subject. By injecting a suspension of allogeneic cells, the invention provides, for example, long-term augmentation of the subadjacent tissue without the disadvantages that accompany the preparation and/or use of presently available materials such as autologous fibroblasts cells or collagen. According to a first aspect of the invention there is provided a method for the augmentation of subcutaneous or dermal tissue in a subject, which method comprises the steps of: (i) providing a suspension of allogeneic dermal fibroblasts; and (ii) injecting an effective volume of the suspension into tissue subadjacent to the subcutaneous or dermal tissue so that the tissue is augmented. The method is preferably cosmetic.Type: GrantFiled: March 8, 2013Date of Patent: March 1, 2016Assignee: INTERCYTEX LIMITEDInventors: Mike Leek, Paul Kemp
-
Publication number: 20130224158Abstract: The present invention provides a method for the repair of subcutaneous or dermal tissue in a subject, comprising in one aspect the injection of a suspension of allogeneic dermal fibroblasts into the subject. By injecting a suspension of allogeneic cells, the invention provides, for example, long-term augmentation of the subadjacent tissue without the disadvantages that accompany the preparation and/or use of presently available materials such as autologous fibroblasts cells or collagen. According to a first aspect of the invention there is provided a method for the augmentation of subcutaneous or dermal tissue in a subject, which method comprises the steps of: (i) providing a suspension of allogeneic dermal fibroblasts; and (ii) injecting an effective volume of the suspension into tissue subadjacent to the subcutaneous or dermal tissue so that the tissue is augmented. The method is preferably cosmetic.Type: ApplicationFiled: March 8, 2013Publication date: August 29, 2013Applicant: INTERCYTEX LIMITEDInventor: INTERCYTEX LIMITED
-
Publication number: 20120328581Abstract: According to the invention there is provided a cosmetic method for the augmentation of subcutaneous or dermal tissue in a subject, which method comprises the steps of: (i) providing a suspension of autologous dermal fibroblasts; and (ii) injecting an effective volume of the suspension into tissue subadjacent to the subcutaneous or dermal tissue so that the tissue is augmented; wherein the fibroblasts are suspended in HYPOTHERMOSOL®, preferably HYPOTHERMOSOL®FRS.Type: ApplicationFiled: July 13, 2012Publication date: December 27, 2012Applicant: Intercytex LimitedInventor: Mike LEEK
-
Publication number: 20070255254Abstract: Baldness or hair loss has been treated using pharmaceutical drugs and/or hair transplant surgery. The present invention relates to an improved method for treating baldness. In one aspect, there is provided a method for inducing hair follicle formation in a dermal layer lying beneath an outer skin surface, comprising delivering inductive dermal sheath cells and/or inductive dermal papilla cells directly into the dermal layer using a controlled delivery device. Delivery of the inductive cells need not be into pre-existing pores. Use of a controlled delivery device for the treatment of baldness is a further aspect of the invention.Type: ApplicationFiled: April 16, 2007Publication date: November 1, 2007Applicant: Intercytex LimitedInventors: Jane Atkins, Michael Leek, Paul Kemp, Richard Wolowacz, Jeffrey Teumer
-
Publication number: 20070253939Abstract: Baldness or hair loss has been treated using pharmaceutical drugs and/or hair transplant surgery. The present invention relates to an improved method for treating baldness. In one aspect, there is provided a method for inducing hair follicle formation in a dermal layer lying beneath an outer skin surface, comprising delivering inductive dermal sheath cells and/or inductive dermal papilla cells directly into the dermal layer using a controlled delivery device. Delivery of the inductive cells need not be into pre-existing pores. Use of a controlled delivery device for the treatment of baldness is a further aspect of the invention.Type: ApplicationFiled: April 16, 2007Publication date: November 1, 2007Applicant: Intercytex LimitedInventors: Jane Atkins, Michael Leek, Paul Kemp, Richard Wolowacz, Jeffrey Teumer
-
Publication number: 20030161815Abstract: The present invention provides a method for inducing organ or tissue formation by delivering inductive cells into an organ or tissue regenerative cellular environment using a controlled delivery device. For the regeneration of hair, the method includes inducing hair follicle formation by delivering inductive cells into a dermal layer using a controlled delivery device. The present invention further provides a method for using a controlled delivery device for the delivery of inductive cells into an organ or tissue regenerative cellular environment to induce organ or tissue formation. The method for using the controlled delivery device includes delivering inductive cells into a dermal layer to induce hair follicle formation.Type: ApplicationFiled: February 12, 2002Publication date: August 28, 2003Applicant: Intercytex LimitedInventors: Richard Gregory Wolowacz, Michael David Leek, Paul David Kemp, Jeffrey Keller Teumer